“Teduglutide can reduce parenteral-support needs in short bowel syndrome.”

01 · Answer

Supported with scope

Controlled trials and the Gattex label support this outcome in dependent short-bowel-syndrome populations.

What kind of evidence this is

Randomized human outcomes. This answer uses a study that assigned people to groups by chance and measured a health outcome.

What this answer covers

Adults and labeled pediatric populations with short bowel syndrome dependent on parenteral support. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.

Question type

Clinical outcomes. What a study measured about people's health, symptoms, or ability to function.